CORC

在结果中检索

CORC

浏览/检索结果: 共29条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients 期刊论文
CANCER MEDICINE, 2022
作者:  Hao, Yue;  Lin, Gen;  Xiang, Jing;  Wang, Wenxian;  Xu, Chunwei
收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文
THORACIC CANCER, 2022
作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo
收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文
THORACIC CANCER, 2022
作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo
收藏  |  浏览/下载：28/0  |  提交时间：2022/12/22
Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Wang, Wenxian;  Huang, Zhangzhou;  Yu, Zongyang;  Zhuang, Wu;  Zheng, Weijun
收藏  |  浏览/下载：31/0  |  提交时间：2020/11/30
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients 期刊论文
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020
作者:  Song, Zhengbo;  Liu, Tianchi;  Shi, Lei;  Yu, Zongyang;  Shen, Qing
收藏  |  浏览/下载：18/0  |  提交时间：2020/10/26
A pH and magnetic dual-response hydrogel for synergistic chemo-magnetic hyperthermia tumor therapy 期刊论文
RSC ADVANCES, 2018, 卷号: 8, 期号: 18, 页码: 9812, 9821
作者:  Zhou, Xiaohan;  Wang, Longchen;  Xu, Yanjun;  Du, Wenxian;  Cai, Xiaojun
收藏  |  浏览/下载：56/0  |  提交时间：2018/12/28
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma 期刊论文
EBIOMEDICINE, 2018, 卷号: 32
作者:  Xiao, Wenjing;  Du, Nan;  Huang, Taoyuan;  Guo, Jinan;  Mo, Xingkui
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/04
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma 期刊论文
EBIOMEDICINE, 2018, 卷号: 32
作者:  Xiao, Wenjing;  Du, Nan;  Huang, Taoyuan;  Guo, Jinan;  Mo, Xingkui
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma 期刊论文
2018, 卷号: 32, 页码: 119
作者:  Xiao, Wenjing[1];  Du, Nan[2];  Huang, Taoyuan[3];  Guo, Jinan[4];  Mo, Xingkui[5]
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/13

©版权所有 ©2017 CSpace - Powered by CSpace